Figure 1a, b shows that in both the RCC cell lines and the RCC tumour tissues, ANGPTL3 expression was correlated with the good response to sorafenib at the mRNA levels, which was further validatedat the protein levels by western blot (Fig. 1c, d). This evidence concerns the gene ANGPTL3 and neoplasm.